Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.

< BACK TO ARCHIVE


2022 Jul 24


Int J Environ Res Public Health


http://www.ncbi.nlm.nih.gov/pubmed/35897370?dopt=Abstract


19


15

Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.

Authors

Comparison of Clonazepam and Tongue Protector in the Treatment of Burning Mouth Syndrome.
Zborowski J, Konopka T
Int J Environ Res Public Health. 2022 Jul 24; 19(15).
PMID: 35897370.

Abstract

BMS is a chronic pain syndrome affecting the oral mucosa. It consists of experiencing a burning or dysesthetic sensation. BMS prevalence varies, with up to 15% among women. An effective treatment is still unattainable.
Read This Paper